biotech – Page 5 – Talk Bio

Actionable Insights Powered by AI

Upstream Biotech Prepares to Join the Wave of Biotech IPOs with Inflammation-Focused Therapies

7 months ago talkbio0Tagged biotech, Biotechnology, healthcare innovation, Industry, Inflammation-Focused Therapies, IPOs, offerings, public entity, Upstream

Biotech IPOs, Upstream Biotech, Inflammation-focused therapies, Biotechnology industry, Public offerings, Healthcare innovation

IO Biotech’s IO102-IO103 Vaccine in Combination with Keytruda Shows Promising Results in Phase 2 Trial for Advanced Squamous Cell Carcinoma of the Head and Neck

7 months ago talkbio0Tagged biotech, Cancer Vaccines, Head and neck structure, Immunotherapy, Io satellite, IO102-IO103, Keytruda, pembrolizumab, Phase 2 trial, Squamous cell carcinoma, Squamous cell carcinoma of the head and neck

IO Biotech, IO102-IO103, Keytruda (pembrolizumab), Phase 2 trial, Squamous cell carcinoma of the head and neck (SCCHN), Cancer vaccine, Immunotherapy

ESMO 2024: IO Biotech’s IO102-IO103 Vaccine in Combination with Pembrolizumab Shows Promising Results in Head and Neck Cancer

7 months ago talkbio0Tagged biotech, Cancer of Neck, Congress (U.S. Legislature), ESMO, Immunotherapy, Io satellite, IO102-IO103, Keytruda, pembrolizumab, Therapeutic Cancer Vaccine

IO Biotech, IO102-IO103, Pembrolizumab (Keytruda), Head and Neck Cancer, ESMO Congress 2024, Therapeutic Cancer Vaccine, Immunotherapy

Biotech IPO Market Sees Rare Upsurge with Triple Listing Success

7 months ago talkbio0Tagged Bicara Therapeutics, Biosciences, biotech, Drug Industry, Flux, IPO, Market, MBX, Stock Surge, Tripleheader, Zenas BioPharma

Biotech IPO, Market Flux, Tripleheader, Bicara Therapeutics, Zenas BioPharma, MBX Biosciences, Stock Surge, Pharmaceutical Industry

Biopharma Layoff Tracker 2024: Industry Continues to Downsize Amid Economic Uncertainty

8 months ago talkbio0Tagged 2024, Biopharma layoffs, biotech, Drug Industry, Economics, Industry, layoffs, trends qualifier

Biopharma layoffs, 2024 layoffs, Pharmaceutical industry downsizing, Biotech industry trends, Economic uncertainty

Candid Therapeutics Launches with $370 Million Funding, Aims to Revolutionize T Cell Engager Market for Autoimmune Diseases

8 months ago talkbio0Tagged Autoimmune Diseases, biotech, Candid, Drug Industry, Ken Song, T-Cell engager

Candid Therapeutics, T Cell Engager, Autoimmune Diseases, Biotech Funding, Ken Song, Pharmaceutical Industry

Connect Biotech Scales Back in China, Reassesses Strategy for Asthma Drug to Compete with Dupixent

8 months ago talkbio0Tagged asthma drug strategy, biotech, China, Connect (action), Dupixent Rival, Industry

Connect Biotech, China workforce reduction, Dupixent rival, asthma drug strategy, biotech industry

Unveiling the Future of Biotech: Top 11 Startups to Watch in 2024

8 months ago talkbio0Tagged biotech, biotech startups, Biotechnology, Industry, innovation, trends qualifier

Biotech startups, Top biotech companies, Biotechnology industry, Emerging biotech trends, Biotech innovation, Biotech awards

Catalent Reports Strong Q4 Results Amid Pending Acquisition by Novo Holdings

8 months ago talkbio0Tagged Acquisition (action), biotech, Catalent, Consumer health, Dosage Forms, Holdings, Q4, results

Catalent, Q4 Results, Novo Holdings, Acquisition, Pharmaceutical, Biotech, Consumer Health

WuXi AppTec Unfazed by BIOSECURE Act Threat, Secures New US Deals

8 months ago talkbio0Tagged AppTec, BIOSECURE, biotech, deals, Industry, pharmaceutical manufacturing, U.S., WuXi

WuXi AppTec, BIOSECURE Act, US Deals, Pharmaceutical Manufacturing, Biotech Industry